Upcoming rare disease clinical trial readouts

What is counted: every rare disease readout in this dataset whose date has not yet passed, taken from the row's own therapeutic-area field rather than guessed from the drug name. 0 of these 8 dates come from company guidance and 8 are estimated primary-completion windows from ClinicalTrials.gov, which shift; each row shows the precision its source actually gave, so a row reading a month or a quarter is one where nobody published a day. 6 of 8 link a trial record or company release. This is a list of dates and sources: it carries no approval odds, no probability of success and no ranking.

This is a floor, not a complete census. 157 of the 269 upcoming readouts we track (58%) carry no therapeutic area, or are tagged only “Other”, and are therefore not counted on this page. Some of them are almost certainly rare disease. We would rather under-count against a field we can check than pad the number by guessing a therapeutic area from a drug name, which is how this site once published a discontinued 2017 compound as an upcoming event.